Search results for: Health Policy and Regulation

To Hell with the 3L! NICE’s Missed Opportunity to Upgrade Health Outcome Measurement

2 March 2022

…describing health states in a way that is relevant across disease areas and health care settings. Its demonstrated ability to detect changes in health resulting from many (perhaps most) health…

The Faces of Regulation: Profit and Price Regulation of the UK Pharmaceutical Industry after the 1998 Competition Act

1 May 2006

…of regulation between the Department of Health as buyer and of the OFT in its role as the agent of general competition law. The paper does not address the OFT…

Europe’s pharmaceutical policy choices – And what the United States stands to learn

18 March 2026

…those trade-offs is the key lesson for policymakers on both sides of the Atlantic.  Cost containment as a conscious policy choice  Across most European health systems, healthcare is financed through…

Achieving Accelerated Patient Access to Cancer Care in Europe 

3 November 2025

…regulatory pathways to support timely access to promising therapies in areas of high unmet medical need. On the other hand, Health Technology Assessment (HTA) and pricing and reimbursement (P&R) processes…

Policy, Organisation and Incentives in Health Systems

Policy, Organisation and Incentives in Health Systems Development of effective health system policy requires an understanding of organisational structures, funding streams, and incentive mechanisms that shape how healthcare interventions and…

The Dynamics of Drug Shortages

9 January 2024

…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…

New OHE model estimates COVID-19 could be associated with costs of £7 billion a year in the UK, without annual autumn vaccinations   

13 October 2025

…analyses in health economics, health policy and health statistics. Our work informs decision–making about health care and pharmaceutical issues at a global level.   All of our work is available…

2024 Innovation Policy Prize 

…policy in health and beyond. Read Andrew’s submissionDownload Thomas Pogge’s Proposal Having received his PhD in philosophy from Harvard, Thomas Pogge is Leitner Professor of Philosophy and International Affairs and…

Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?

12 April 2024

…1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006. Available at: https://health.ec.europa.eu/system/files/2023-04/com_2023_193_1_act_en.pdf [Accessed 4 May 2023]. European Federation of Pharmaceutical…